Dr. Daniel Landi, MD
Claim this profileDuke University Medical Center
Studies Cerebral Gliomas
Studies Brain Tumor
10 reported clinical trials
15 drugs studied
Area of expertise
1Cerebral Gliomas
Stage IV
Stage I
Stage II
2Brain Tumor
Stage I
Stage II
H3K27M positive
Affiliated Hospitals
Clinical Trials Daniel Landi, MD is currently running
Combination Therapy
for Brain Cancer
This trial is testing a combination of three drugs to treat a specific type of brain tumor called diffuse midline gliomas (DMGs). These drugs aim to stop the tumor from growing by blocking enzymes that the cancer cells need. The trial focuses on patients with DMGs because current treatments are not very effective for them.
Recruiting1 award Phase 229 criteria
PEP-CMV Vaccine
for Pediatric Brain Tumor
This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with newly-diagnosed high-grade glioma (HGG) or diffuse intrinsic pontine glioma (DIPG) as well as recurrent medulloblastoma (MB). PEP-CMV is a vaccine mixture of a peptide referred to as Component A. Component A is a synthetic long peptide (SLP) of 26 amino acid residues from human pp65. The SLPs encode multiple potential class I, class II, and antibody epitopes across several haplotypes. Component A will be administered as a stable water:oil emulsion in Montanide ISA 51. Funding Source - FDA OOPD
Recruiting1 award Phase 2
More about Daniel Landi, MD
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Daniel Landi, MD has experience with
- D2C7-IT
- 2141-V11
- PEP-CMV
- Atezolizumab
- PVSRIPO
- Avapritinib
Breakdown of trials Daniel Landi, MD has run
Cerebral Gliomas
Brain Tumor
Malignant Glioma
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Landi, MD specialize in?
Daniel Landi, MD focuses on Cerebral Gliomas and Brain Tumor. In particular, much of their work with Cerebral Gliomas has involved Stage IV patients, or patients who are Stage I.
Is Daniel Landi, MD currently recruiting for clinical trials?
Yes, Daniel Landi, MD is currently recruiting for 6 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Daniel Landi, MD has studied deeply?
Yes, Daniel Landi, MD has studied treatments such as D2C7-IT, 2141-V11, PEP-CMV.
What is the best way to schedule an appointment with Daniel Landi, MD?
Apply for one of the trials that Daniel Landi, MD is conducting.
What is the office address of Daniel Landi, MD?
The office of Daniel Landi, MD is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.